Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP459412.RAiCTePHyhE0_FiDZ9ptGsYa3QzNBfSMQsnoo_wCi2wAg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP459412.RAiCTePHyhE0_FiDZ9ptGsYa3QzNBfSMQsnoo_wCi2wAg130_assertion type Assertion NP459412.RAiCTePHyhE0_FiDZ9ptGsYa3QzNBfSMQsnoo_wCi2wAg130_head.
- NP459412.RAiCTePHyhE0_FiDZ9ptGsYa3QzNBfSMQsnoo_wCi2wAg130_assertion description "[Furthermore, our data show that pharmacological concentrations of celecoxib may interfere with the proapoptotic action of R(+)-MA and anandamide, suggesting that cotreatment with COX-2 inhibitors could diminish glioma regression induced by these compounds.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP459412.RAiCTePHyhE0_FiDZ9ptGsYa3QzNBfSMQsnoo_wCi2wAg130_provenance.
- NP459412.RAiCTePHyhE0_FiDZ9ptGsYa3QzNBfSMQsnoo_wCi2wAg130_assertion evidence source_evidence_literature NP459412.RAiCTePHyhE0_FiDZ9ptGsYa3QzNBfSMQsnoo_wCi2wAg130_provenance.
- NP459412.RAiCTePHyhE0_FiDZ9ptGsYa3QzNBfSMQsnoo_wCi2wAg130_assertion SIO_000772 15361550 NP459412.RAiCTePHyhE0_FiDZ9ptGsYa3QzNBfSMQsnoo_wCi2wAg130_provenance.
- NP459412.RAiCTePHyhE0_FiDZ9ptGsYa3QzNBfSMQsnoo_wCi2wAg130_assertion wasDerivedFrom befree-2016 NP459412.RAiCTePHyhE0_FiDZ9ptGsYa3QzNBfSMQsnoo_wCi2wAg130_provenance.
- NP459412.RAiCTePHyhE0_FiDZ9ptGsYa3QzNBfSMQsnoo_wCi2wAg130_assertion wasGeneratedBy ECO_0000203 NP459412.RAiCTePHyhE0_FiDZ9ptGsYa3QzNBfSMQsnoo_wCi2wAg130_provenance.